Bullfrog AI Holdings, Inc. Common Stock (BFRG )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol BFRG
- Company Bullfrog AI Holdings, Inc. Common Stock
- Price $1.68
- Changes Percentage 60
- Change 0.63
- Day Low $1.19
- Day High $1.96
- Year High $2.2
- Year Low $0.43
- Market Cap $17,818,690
- Price Avg 50 EMA (D) $0.6
- Price Avg 200 EMA (D) $1.1
- Exchange NASDAQ
- Volume 192,707,693
- Average Volume 7,600,560
- Open $1.2
- Previous Close $1.05
- EPS -0.63
- PE -2.67
- Earnings Announcement 2026-05-12 04:00:00
- Shares Outstanding $10,606,363
Company brief: BULLFROG AI HOLDINGS, INC. COMMON STOCK (BFRG )
- Healthcare
- Medical - Healthcare Information Services
- Mr. Vininder Singh
- https://www.bullfrogai.com
- US
- N/A
- 02-13-2023
- US12021E1091
BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.
BFRG Corporation News
BullFrog AI Shares Surge On Deal With Top Pharma Company For MDD Drug Targets
benzinga.com -- BullFrog said the agreement will utilize its end-to-end analytical AI platform to accelerate the partner's drug discovery and clinical development program for MDD....
Bullfrog AI stock offers a rare opportunity for investors to take profit
invezz.com -- Bullfrog AI Inc more than doubled on Mar. 30 after announcing a landmark commercial agreement with a “top 5” pharma leader to identify novel therapeutic targets for Major Depressive Disorder. In i...